Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 8,270 KRW
Change Today +340.00 / 4.29%
Volume 1.0M
As of 2:13 AM 05/6/15 All times are local (Market data is delayed by at least 15 minutes).

geneonelifescience inc (011000) Snapshot

Open
7,800
Previous Close
7,930
Day High
8,840
Day Low
7,640
52 Week High
10/17/14 - 15,075
52 Week Low
06/27/14 - 4,192
Market Cap
133.0B
Average Volume 10 Days
772.0K
EPS TTM
-495.00
Shares Outstanding
16.1M
EX-Date
03/16/07
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for GENEONELIFESCIENCE INC (011000)

Related News

No related news articles were found.

geneonelifescience inc (011000) Related Businessweek News

No Related Businessweek News Found

geneonelifescience inc (011000) Details

GeneOne Life Science Inc., a biopharmaceutical company, engages in the research and development of DNA vaccines to prevent and treat incurable diseases in South Korea and internationally. Its product pipeline includes VGX-3400, a DNA vaccine, which has completed Phase I clinical trials for the prevention of avian influenza; VGX-3500, a prophylactic pre-pandemic influenza DNA vaccine that is in Phase I clinical trials for protection against swine, avian, and seasonal influenza; and FLUPRIME, a trivalent influenza vaccine, which is in Phase I clinical trials for the prevention of the outbreak of seasonal flu. The company is also developing VGX-6150, a therapeutic DNA vaccine that is in Phase I clinical trials for the treatment of hepatitis C; and therapeutic DNA vaccines for the treatment of hepatitis B. In addition, it is involved in the contract manufacturing activities for various pre-clinical and clinical studies for institutions, universities, governments, and biotechnology companies. The company was formerly known as VGX International Inc. and changed its name to GeneOne Life Science Inc. in April 2014. GeneOne Life Science Inc. is headquartered in Seoul, South Korea.

geneonelifescience inc (011000) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

geneonelifescience inc (011000) Key Developments

GeneOne Life Science Inc., Annual General Meeting, Mar 27, 2015

GeneOne Life Science Inc., Annual General Meeting, Mar 27, 2015., at 09:00 Korea Standard Time. Location: Teheran-ro, Korea Institute of Science and Technology, Hall 7. Agenda: To consider the audit report; to consider the sales report; to approve the financial statements for the year ended December 31, 2014; and to consider other issues.

GeneOne Life Science Inc. Proposes Changes in Articles of Incorporation

GeneOne Life Science Inc. proposed some changes in Articles of Incorporation at its EGM to be held on December 18, 2014.

GeneOne Life Science Inc., Special/Extraordinary Shareholders Meeting, Dec 18, 2014

GeneOne Life Science Inc., Special/Extraordinary Shareholders Meeting, Dec 18, 2014., at 09:00 Korea Standard Time. Location: Teheran-ro, Gangnam-gu. Agenda: To consider some changes in Articles of Incorporation.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
011000:KS 8,270.00 KRW +340.00

011000 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 011000.
View Industry Companies
 

Industry Analysis

011000

Industry Average

Valuation 011000 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6.2x
Price/Book 4.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENEONELIFESCIENCE INC, please visit www.genels.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.